| Authors: |
Akdemir KC; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Le VT; Salk Institute for Biological Studies, La Jolla, CA, USA., Chandran S; Salk Institute for Biological Studies, La Jolla, CA, USA., Li Y; Wellcome Trust Sanger Institute, Cambridge, UK., Verhaak RG; Division of Computational Biology, The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA., Beroukhim R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Cancer Biology, Dana-Farber Cancer Institute, Cambridge, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA., Campbell PJ; Wellcome Trust Sanger Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Chin L; Institute for Health Transformation University of Texas, Houston, TX, USA., Dixon JR; Salk Institute for Biological Studies, La Jolla, CA, USA., Futreal PA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. afutreal@mdanderson.org. |
